These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2765888

  • 1. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies.
    Manaye KF, Sonsalla PK, Barnett G, Heikkila RE, Woodward DJ, Smith WK, German DC.
    Brain Res; 1989 Jul 10; 491(2):307-15. PubMed ID: 2765888
    [Abstract] [Full Text] [Related]

  • 2. Increased midbrain dopaminergic cell activity following 2'CH3-MPTP-induced dopaminergic cell loss: an in vitro electrophysiological study.
    Bernardini GL, Speciale SG, German DC.
    Brain Res; 1990 Sep 10; 527(1):123-9. PubMed ID: 1980838
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in mice.
    Abdel-Wahab MH.
    J Biochem Mol Toxicol; 2005 Sep 10; 19(1):32-41. PubMed ID: 15736157
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
    Sonsalla PK, Youngster SK, Kindt MV, Heikkila RE.
    J Pharmacol Exp Ther; 1987 Sep 10; 242(3):850-7. PubMed ID: 2888874
    [Abstract] [Full Text] [Related]

  • 7. Neurotoxicity of an MPTP analogue, 2'CH3-MPTP, on monoaminergic systems in the mouse brain.
    Gupta M, Chen XL.
    Ann N Y Acad Sci; 1992 May 11; 648():283-5. PubMed ID: 1353331
    [No Abstract] [Full Text] [Related]

  • 8. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S, Fujitake J, Kuno S, Sano Y.
    Neurosci Lett; 1988 Jul 19; 90(1-2):57-62. PubMed ID: 2901058
    [Abstract] [Full Text] [Related]

  • 9. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.
    German DC, Nelson EL, Liang CL, Speciale SG, Sinton CM, Sonsalla PK.
    Neurodegeneration; 1996 Dec 19; 5(4):299-312. PubMed ID: 9117541
    [Abstract] [Full Text] [Related]

  • 10. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
    German DC, Dubach M, Askari S, Speciale SG, Bowden DM.
    Neuroscience; 1988 Jan 19; 24(1):161-74. PubMed ID: 3259295
    [Abstract] [Full Text] [Related]

  • 11. Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Deutch AY, Elsworth JD, Goldstein M, Fuxe K, Redmond DE, Sladek JR, Roth RH.
    Neurosci Lett; 1986 Jul 11; 68(1):51-6. PubMed ID: 3487756
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
    Fries DS, de Vries J, Hazelhoff B, Horn AS.
    J Med Chem; 1986 Mar 11; 29(3):424-7. PubMed ID: 3485197
    [Abstract] [Full Text] [Related]

  • 13. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
    Heikkila RE, Sieber BA, Manzino L, Sonsalla PK.
    Mol Chem Neuropathol; 1989 Jun 11; 10(3):171-83. PubMed ID: 2669769
    [No Abstract] [Full Text] [Related]

  • 14. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M, Mariani AP, Neff NH.
    Brain Res; 1989 Apr 10; 484(1-2):297-303. PubMed ID: 2565752
    [Abstract] [Full Text] [Related]

  • 15. Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice.
    Sundström E, Strömberg I, Tsutsumi T, Olson L, Jonsson G.
    Brain Res; 1987 Mar 03; 405(1):26-38. PubMed ID: 2882814
    [Abstract] [Full Text] [Related]

  • 16. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
    Date I, Asari S, Nishimoto A, Felten DL.
    No To Shinkei; 1990 Nov 03; 42(11):1035-40. PubMed ID: 2076347
    [Abstract] [Full Text] [Related]

  • 17. Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum.
    Elsworth JD, Deutch AY, Redmond DE, Sladek JR, Roth RH.
    Life Sci; 1987 Jan 12; 40(2):193-202. PubMed ID: 3491946
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice.
    Boeckler F, Leng A, Mura A, Bettinetti L, Feldon J, Gmeiner P, Ferger B.
    Biochem Pharmacol; 2003 Sep 15; 66(6):1025-32. PubMed ID: 12963489
    [Abstract] [Full Text] [Related]

  • 19. Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTP.
    Sziráki I, Kardos V, Patthy M, Pátfalusi M, Gaál J, Solti M, Kollár E, Singer J.
    J Neural Transm Suppl; 1994 Sep 15; 41():207-19. PubMed ID: 7931228
    [Abstract] [Full Text] [Related]

  • 20. Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart.
    Wallace RA, Boldry R, Schmittgen T, Miller D, Uretsky N.
    Life Sci; 1984 Jul 16; 35(3):285-91. PubMed ID: 6146909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.